EUR 2.36
(-0.84%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.35 Million EUR | 17.14% |
2022 | 1.15 Million EUR | 137.28% |
2021 | 487.68 Thousand EUR | -14.38% |
2020 | 569.59 Thousand EUR | 33.96% |
2019 | 425.19 Thousand EUR | 59.04% |
2018 | 267.34 Thousand EUR | 1.48% |
2017 | 263.45 Thousand EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1.1 Million EUR | 0.0% |
2023 Q4 | 1.35 Million EUR | 0.0% |
2023 Q2 | 1.01 Million EUR | 0.0% |
2023 FY | 1.35 Million EUR | 17.14% |
2022 Q2 | 871.98 Thousand EUR | 0.0% |
2022 Q4 | 1.15 Million EUR | 0.0% |
2022 FY | 1.15 Million EUR | 137.28% |
2021 Q4 | 487.68 Thousand EUR | 0.0% |
2021 FY | 487.68 Thousand EUR | -14.38% |
2021 Q2 | 454.97 Thousand EUR | 0.0% |
2020 Q2 | 491.49 Thousand EUR | 0.0% |
2020 Q4 | 569.59 Thousand EUR | 0.0% |
2020 FY | 569.59 Thousand EUR | 33.96% |
2019 Q2 | 273.93 Thousand EUR | 0.0% |
2019 Q4 | 425.19 Thousand EUR | 0.0% |
2019 FY | 425.19 Thousand EUR | 59.04% |
2019 Q3 | 425.19 Thousand EUR | 55.22% |
2018 Q4 | 267.34 Thousand EUR | 0.0% |
2018 FY | 267.34 Thousand EUR | 1.48% |
2017 FY | 263.45 Thousand EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Philogen S.p.A. | 2.24 Million EUR | 39.701% |
Ulisse Biomed S.p.A. | 1.98 Million EUR | 31.723% |